Esperion Therapeutics
ESPR
#6822
Rank
ยฃ0.34 B
Marketcap
ยฃ1.76
Share price
8.06%
Change (1 day)
137.02%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ0.14 Billion

According to Esperion Therapeutics's latest financial reports the company has ยฃ0.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ64.55 M-53.19%
2022-12-31ยฃ0.13 B-28.21%
2021-12-31ยฃ0.19 B-14.13%
2020-12-31ยฃ0.22 B46.12%
2019-12-31ยฃ0.15 B42.89%
2018-12-31ยฃ0.10 B-27.66%
2017-12-31ยฃ0.14 B-13.61%
2016-12-31ยฃ0.17 B19.72%
2015-12-31ยฃ0.14 B110.69%
2014-12-31ยฃ67.98 M86.7%
2013-12-31ยฃ36.41 M803.82%
2012-12-31ยฃ4.02 M298.56%
2011-12-31ยฃ1.01 M
2002-12-31ยฃ27.97 M-42.29%
2001-12-31ยฃ48.47 M3.02%
2000-12-31ยฃ47.05 M1187.77%
1999-12-31ยฃ3.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.59 B 303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.72 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.70 B 5,157.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.58 B 5,075.01%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.19 B 31.93%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.23 B 63.74%๐Ÿ‡บ๐Ÿ‡ธ USA